Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
69
datasets available to search
ShareScore release 0.9.0
Dataset results
69 results for “middle income countries”
Data for: Characterizing multi-criteria decision analysis, risk stratification, and hotspot analysis methods to optimise disease policymaking and evidence translation for medicines in low- and middle-income countries: A scoping review
Open the record for dataset details and reuse information.
Mapping the prevalence of household-scale livestock ownership by animal taxon in low- and middle-income countries
Open the record for dataset details and reuse information.
Strategies and interventions to strengthen pharmacovigilance systems in low- and middle-income countries: A scoping review
<div><strong>Objectives</strong></div> <div>The slow progress of pharmacovigilance (PV) in low-and-middle-income countries (LMIC) raises questions about core challenges on the growth of PV, and the appropriateness of strategies used so far to develop PV. Therefore, this scoping review aims to describe strategies and interventions to strengthen PV in LMIC and to propose recommendations for future investments in PV capacity building.</div> <div> </div> <div><strong>Inclusion criteria</strong></div> <div>Publications included were primary studies, articles, and policy and guideline papers, describing interventions to strengthen PV in LMIC. </div> <div> </div> <div><strong>Methods</strong></div> <div>The review was conducted following the Joanna Briggs Institute (JBI) guidelines on conducting scoping reviews. Literature searches were performed in MEDLINE, EMBASE, Web of Science, PDQ-evidence, CINAHL and relevant websites from 1990 to January 2021. Two reviewers independently screened titles, abstracts and full-texts. One reviewer performed data extraction and descriptive analysis, which were reviewed by two other reviewers.</div> <div> </div> <div><strong>Results</strong></div> <div>10,922 unique titles were screened and 152 were eligible for full text review. Of these, 57 and an additional 13 reports from grey literature fulfilled eligibility criteria for inclusion in the review. These were grouped into two categories: i) Interventions aimed at increasing PV knowledge and adverse drug reactions (ADR) reporting (45 papers), primarily education of healthcare professionals (HCP), alone or in combination with other interventions such as mobile and electronic reporting; ii) Interventions aimed at strengthening various components of the national PV system (25 papers), describing strategies or mixed interventions implemented at the national level, targeting different components of the national PV system.</div> <div> </div> <div><strong>Conclusions</strong></div> <div>Results of this review suggest that educating HCP on ADR reporting is the most common approach to build PV capacity in LMIC. Though important, education alone is insufficient and should ideally be organised within the holistic framework of strengthening national PV systems, with a focus on building capacity for advanced activities such as signal detection.</div>
E-MhGAP Intervention Guide in Low- and Middle-income Countries: Proof-of-concept for Impact and Acceptability
ClinicalTrials.gov study NCT04522453. IPD Sharing: YES. Countries: 2. Publications: 2.
Development, Field Testing and Evaluation of the Efficacy of a Hand-held, Portable and Affordable Thermo-coagulator to Prevent Cervical Cancer in Low- and Middle-income Countries
ClinicalTrials.gov study NCT02956239. IPD Sharing: YES. Countries: 1. Publications: 3.
Detecting and Treating High Blood Pressure in Aboriginal Population and Low and Middle Income Countries
ClinicalTrials.gov study NCT02111226. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Practice of Ventilation in Middle-Income Countries
ClinicalTrials.gov study NCT03188770. IPD Sharing: NO. Countries: 10. Publications: 5.
Maternal Employment in Low and Middle-income Countries and Infant Feeding
ClinicalTrials.gov study NCT03209999. IPD Sharing: NO. Countries: 1. Publications: 1.
Development and Evaluation of a ChlorHexidine Gluconate bAthing pRotocol for Healthcare Settings in Low- and Middle-income Countries
ClinicalTrials.gov study NCT06590675. IPD Sharing: NO. Countries: 1. Publications: 13.
Total Energy Expenditure Across the Life Course in Low-and Middle-Income Countries -- Chinese Children
ClinicalTrials.gov study NCT07054294. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries
ClinicalTrials.gov study NCT06989502. IPD Sharing: UNDECIDED. Countries: 3. Publications: 5.
Hypothermia for Encephalopathy in Low and Middle-Income Countries Trial
ClinicalTrials.gov study NCT02387385. IPD Sharing: Not stated. Countries: 3. Publications: 5.
Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
ClinicalTrials.gov study NCT03666767. IPD Sharing: YES. Countries: 1. Publications: 1.
GECo: Implementation and Effectiveness of COPD Case-Finding in Low and Middle Income Countries
ClinicalTrials.gov study NCT03365713. IPD Sharing: NO. Countries: 3. Publications: 2.
A Community Dance Intervention Engaging Breast Cancer Survivors in a Middle-income Country
ClinicalTrials.gov study NCT05252780. IPD Sharing: NO. Countries: 1. Publications: 51.
GECo: Implementation and Effectiveness of COPD Self Management Action Plans in Low and Middle Income Countries
ClinicalTrials.gov study NCT03359915. IPD Sharing: NO. Countries: 3. Publications: 2.
Data from: Task shifting interventions for cardiovascular risk reduction in low-and middle-income countries: a systematic review of randomized controlled trials
Open the record for dataset details and reuse information.
Strategies and interventions to strengthen pharmacovigilance systems in low- and middle-income countries: A scoping review
Open the record for dataset details and reuse information.
Data from: Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: a qualitative study
Background: Studies around the world have shown that interactions between pharmaceutical companies, pharmacists and physicians have a great influence on prescribing and drug dispensing practices. In middle-income countries, the nature and extent of these interactions have not been well researched. Our objectives were to qualitatively explore the nature of the interactions between pharmaceutical companies, physicians and pharmacists, their impact on drug prescription and dispensing practices in Lebanon. Methods and Findings: We used grounded theory approach as well as the known sponsor, purposive, and snowballing sampling strategies to identify interviewees from the three respective groups: physicians, pharmacists, and pharmaceutical representatives. We conducted semi-structured and analyzed transcripts thematically. 6 pharmaceutical representatives, 13 physicians and 13 pharmacists participated in the study. The following themes emerged: purpose and driver for the interactions, nature of the interactions, incentives, impact on prescription practices, ethical considerations, and suggestions for managing the interactions. The main purposes for the interaction were educational, promotional, and monitoring prescription practices and dispensing, while the main drivers for these interactions were market potential and neighborhood socio-economic status. Physicians, pharmacists and pharmaceutical representatives who engage in these interactions benefit from a variety of incentives, some of which were characterized as unethical. It appears that pharmaceutical companies give prominence to selected physicians within their communities. Although members of the three interviewed groups refer to some of the interactions as being problematic, they described a culture of acceptance of gift giving. We developed a framework that depicts the prevailing politico-cultural environment, the interactions between the three professional groups, and their impact on drug prescription. Underreporting is the main limitation of this study. Conclusion: Interactions between physicians, pharmacists and pharmaceutical representatives are frequent. Although these interactions can be beneficial, they still have a substantial effect on drug prescription and dispensing practices. Hence, the need for new policies that regulate these interactions and penalize any misconduct.
Psychometric Properties of an Instrument Measuring Mon-keypox Knowledge, Perception, and Beliefs of Health Threat in Health Science Students in a Middle-Income Country
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.